A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy with Ginseng for Patients on Treatment with Regorafenib
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to test whether ginseng can reduce the severity of the fatigue caused by regorafenib.
Description
The purpose of this study is to assess fatigue with the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) and Patient-Reported Outcomes Measurement Information System (PROMIS) form for each group (Regorafenib = No Ginseng vs. Regorafenib + Ginseng) to determine if 2000 mg of American Ginseng for 8 weeks has an impact on the fatigue score.
Details
| Condition | colon cancer |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX6793 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.